8 studies found for:    s0806
Show Display Options
Rank Status Study
1 Active, not recruiting Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Conditions: Stage II Contiguous Adult Diffuse Large Cell Lymphoma;   Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma
Interventions: Drug: Vorinostat;   Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Vincristine Sulfate;   Drug: Prednisone;   Other: Laboratory Biomarker Analysis
2 Completed
Has Results
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
3 Completed A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil
Conditions: HIV;   HIV Infections
Intervention:
4 Completed
Has Results
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: placebo
5 Completed FACTO Study (Foster® As Complete Treatment Option)
Condition: Asthmatic Patients
Interventions: Drug: FOSTER;   Drug: Seretide
6 Completed Green Tea and Reduction of Breast Cancer Risk
Condition: Breast Cancer
Interventions: Drug: Green tea extract supplement;   Other: Placebo
7 Active, not recruiting
Has Results
Proton Therapy for Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Radiation: Proton Radiation Plan;   Radiation: Conventional Photon Radiation Plan;   Radiation: Intensity Modulated Radiation Plan
8 Recruiting Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer;   Cardiac Toxicity
Interventions: Drug: Coreg CR®;   Drug: lisinopril;   Other: placebo

Indicates status has not been verified in more than two years